Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891554-00-500156
Filing Date
2000-10-30
Accepted
2000-10-30 00:00:00
Documents
5
Period of Report
2000-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K d23875_10k.txt 10-K 264601
2 EXHIBIT 10.21 d23875_ex10-21.txt EX-10.21 55430
3 EXHIBIT 23.1 d23875_ex23-1.txt EX-23.1 1616
4 EXHIBIT 99.1 d23875_ex99-1.txt EX-99.1CHARTER 18188
5 EXHIBIT 27 d23875_ex-27.frm EX-27 2335
  Complete submission text file 0000891554-00-500156.txt   344217
Mailing Address 225 BELLEVILLE AVE 225 BELLEVILLE AVE BLOOMFIELD NJ 07003
Business Address 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 9737488082
ALFACELL CORP (Filer) CIK: 0000708717 (see all company filings)

EIN.: 222369085 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-11088 | Film No.: 749405
SIC: 2836 Biological Products, (No Diagnostic Substances)